States with medical marijuana laws saw 20 percent drop in some opioid prescriptions
States with active medical marijuana laws saw certain opioid prescription rates drop nearly 20 percent compared to states without medical marijuana programs, according to a first-of-its-kind study out of Columbia University’s Irving Medical Center.
Authors said the findings underscore the importance of providing patients with pain management alternatives, such as cannabis, in efforts to reduce opioid use.
Stories you may be interested in
Updated Arfinn Med Scheduler
As your practice begins to grow, it’s important that your booking system is able to keep up. That’s why Arfinn Med has just released, in its newest update, the multi-view scheduling and booking platform. This allows you and/or your staff the ability to customize appointment types, hours of availability, display name, and confirmation emails for…
Read More 
The Lack of Clinical Trials in the Medical Marijuana Industry
As time goes on, medical marijuana is starting to break barriers in various states across the country. Out of the 50 states, 33 have approved a comprehensive medical marijuana program (NCSL). Currently, marijuana, medical or recreational, is illegal at the federal level, despite legalization in various states. Many medical professionals are interested in prescribing medical…
Read More 
Florida medical marijuana dispensary now sells the state’s first cannabis tablet
Even though Florida residents can finally smoke medical marijuana, one of the state’s largest cannabis companies is now offering it in tablet form. The company Curaleaf released the state’s first cannabis tablet on Sunday. The company’s two Orlando locations, at 775 N Semoran Blvd. and 12402 S Orange Blossom Trail, sell the mint-flavored tablets for $35 for a 30-quantity, child-resistant package. Read…
Read More 
July Updates
In our quest to save medical marijuana clinics valuable time, Arfinn Med has continued to release new functionality that improves EMR workflows. This has led to the development of our new telehealth platform, new automated patient intake emails, and generating all state required documentation. Continuing on our quest, we are proud to release our new…
Read More 
CEO Spotlight: James West
As a former academic coordinator for the City University of New York Research Foundation and Medgar Evers College, CEO and co-founder of Arfinn Med, James West, has extensive experience in adult education and professional training programming. James put this extensive education to good use when he noticed that there was a direct need for a…
Read More 
Cannabis for Treating IBD: Hope or Hype?
Nausea, abdominal pain and changes in appetite. These are all things that can significantly impact one’s wellbeing if left untreated, yet they have all shown marked improvements when associated with cannabis. Yet, less is known about the effects of cannabis on inflammatory bowel disease, or IBD, a chronic inflammatory condition that impacts the gastrointestinal tract…
Read More